Portada Terra Colombia >Invertia 
INDICE BVC  0.68%  |  BOVESPA (BRASIL)  0.77%  |  NASDAQ CMP  0.00%  |  DOW JONES  0.91%
 
 Colombia 23:27 HS - 18/06/2013  NoticiasAcciones

Diccionario

Busca una palabra?

Encuéntrela aquí

Empresas

- Resumen

 CELGENE CORP. (CELG)     

Último  ( 18/06/2013 ):
120.24
DOLARES
Cambio:
2.54
Máxima:
120.45
Máx52s:
131.82
Volumen:
1827925
Cambio%:
2.16
Mínima:
117.72
Mín52s:
61.23
Apertura:
118.28
Recomiende esta acción:

 

16 Ene 2013 - Research and Markets: Global Tissue Engineering and Cell Therapy Market 2011-2015 with Advanced Cell Technology Inc. and Medtronic Inc. Dominating

Research and Markets (http://www.researchandmarkets.com/research/fvcpcj/global_tissue) has announced the addition of the "Global Tissue Engineering and...

04 Dic 2012 - Research and Markets: Global Heparin Market 2011-2015

Research and Markets (http://www.researchandmarkets.com/research/8grggv/global_heparin) has announced the addition of the "Global Heparin Market 2011-2015"...

16 Oct 2012 - RBCC: Could Stem Cells Be Key to Promising Autism Therapy?

Rainbow Coral Corp. (OTCBB: RBCC) subsidiary Rainbow BioSciences will keep a close eye on a new study that could potentially lead to stem cell therapies...

04 Oct 2012 - RBCC: NASA Bioreactor Could Speed Parkinson?s Research

Stem cell research may hold the key to a cure for Parkinson?s disease. The only problem is, stem cell research hasn?t advanced as quickly as patients need...

27 Sep 2012 - RBCC: Stem Cell Market Poised for Billion-Dollar Growth

As Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp. (OTCBB: RBCC), works to acquire licensing for commercial use of NASA-developed stem...

26 Sep 2012 - Research and Markets: Acute Myeloid Leukemia (AML) Therapeutics - Global Strategic Business Report

Research and Markets (http://www.researchandmarkets.com/research/6z7djx/acute_myeloid) has announced the addition of the "Acute Myeloid Leukemia (AML)...

19 Sep 2012 - RBCC Initiates Talks to Acquire License for NASA Bioreactor Technology

Rainbow Biosciences, the biotech subsidiary of Rainbow Coral Corp. (OTCBB: RBCC), announced today that it has engaged Regenetech in discussions regarding...

17 Sep 2012 - RBCC Expands Cell Culturing Focus to Include Adult Stem Cells

Rainbow Biosciences, the biotechnology subsidiary of Rainbow Coral Corp. (OTCBB: RBCC), announced today that it will expand its focus on technology capable...

10 Ago 2012 - Research and Markets: Global Pharmaceuticals Market 2011-2015: The Global Pharmaceuticals market to grow at a CAGR of 7 percent over the period 2011-2015

Research and Markets (http://www.researchandmarkets.com/research/t2brxw/global_pharmaceuti) has announced the addition of the "Global Pharmaceuticals Market...

21 Jun 2012 - Acciones EEUU caen tras decepcionantes datos económicos

NUEVA YORK (Reuters) - Las acciones estadounidenses bajaban el jueves, después que a una serie de datos que mostraron una desaceleración global se sumaron...

19 Jun 2012 - Firmas biotecnológicas avanzan en 2011, futuro incierto: informe

Por Toni Clarke Junio 19 (Reuters) - El desempeño financiero agregado de las firmas biotecnológicas en cuatro de los mayores mercados del mundo mejoró...

Conozca Invertia en otros países | Página de inicio | Contáctenos
Aviso legales | Protección de datos © Copyright 2013, Terra Networks, S.A.

Nota: Todas las cotizaciones se muestran con al menos 20 minutos de retraso.